九游会·J9-中国官方网站|真人游戏第一品牌

News Center

Luye Pharma’s LY03005 Approved by China’s CDE to Conduct Phase III Clinical Trial for th...

2022-03-22 MORE>
Luye Pharma Files New Drug Application for Lurbinectedin in Hong Kong

For the Treatment of Metastatic Small Cell Lung Cancer

2022-03-08 MORE>
Luye Pharma and Biostar Enter into a Partnership for Marketing Innovative Anticancer Drug ...

2022-02-22 MORE>
Marketing Authorization Application for Luye Pharma's Innovative Anticancer Formulation Go...

2021-12-30 MORE>
Luye Pharma Releases Top-Line Results from a Phase II Clinical Trial of Its New Antidepres...

Showing a comprehensive antidepressant efficacy and a good safety profile

2021-12-23 MORE>
Luye Pharma Grants Gensci Exclusive Commercialization Rights of Rivastigmine Transdermal P...

2021-12-23 MORE>

Total:131 / Page:22 First Prev 8 9 10 11 12 Next Last

LUYE All Rights Reserved Privacy policy Terms of use

TOP

<tfoot id='np8dm'></tfoot>

<legend id='np8dm'><style id='np8dm'><dir id='np8dm'><q id='np8dm'></q></dir></style></legend>

<i id='np8dm'><tr id='np8dm'><dt id='np8dm'><q id='np8dm'><span id='np8dm'><b id='np8dm'><form id='np8dm'><ins id='np8dm'></ins><ul id='np8dm'></ul><sub id='np8dm'></sub></form><legend id='np8dm'></legend><bdo id='np8dm'><pre id='np8dm'><center id='np8dm'></center></pre></bdo></b><th id='np8dm'></th></span></q></dt></tr></i><div id='np8dm'><tfoot id='np8dm'></tfoot><dl id='np8dm'><fieldset id='np8dm'></fieldset></dl></div>